Patents by Inventor Bingbin Zhang

Bingbin Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use Therefor
    Publication number: 20220324868
    Abstract: Disclosed in the present invention are a pyrazolone-fused pyrimidine compound, and a preparation method and a use therefor. Provided in the present invention is a pyrazolone-fused pyrimidine compound as in formula (I), said compound having better inhibitory activity towards WEE1 kinase.
    Type: Application
    Filed: August 28, 2020
    Publication date: October 13, 2022
    Inventors: Qian WANG, Guoyong HUO, Guangxin XIA, Jiangsong LOU, Sijie SHU, Hui GE, Lin ZHANG, Chen SHI, Zhihui ZHANG, Yu MAO, Bingbin ZHANG, Jianxin YU, Yanjun LIU, Ying KE, Chi ZHANG
  • Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications Thereof
    Publication number: 20220259210
    Abstract: Disclosed are a pyrazolone-fused pyrimidine compound, a preparation method for same and applications thereof. Provided in the present invention is the pyrazolone-fused pyrimidine compound as represented by formula (II). The compound has improved inhibitory activity with respect to WEE1 kinase.
    Type: Application
    Filed: June 28, 2020
    Publication date: August 18, 2022
    Inventors: Qian WANG, Sijie SHU, Guangxin XIA, Hui GE, Bingbin ZHANG, Guoyong HUO, Lin ZHANG, Chen SHI, Jiangsong LOU, Chi ZHANG, Zhihui ZHANG, Yu MAO, Jianxin YU, Ying KE, Yanjun LIU
  • Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing
    Publication number: 20170334927
    Abstract: A nitroimidazole compound represented by general formula (I) or an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a preparation method therefore, and use thereof in manufacturing drugs for the treating infectious diseases caused by mycobacterium tuberculosis. Specific groups in general formula (I) are as defined in the specification.
    Type: Application
    Filed: December 11, 2015
    Publication date: November 23, 2017
    Applicant: Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd.
    Inventors: Chuansheng Zhao, Bingbin Zhang, Tongrui Zhou, Tiancai Wang, Jun Sun, Houxing Fan